Nokia Board of Directors convenes Annual General Meeting 2016
Apr 21, 2016 10:13 am UTC| Business
Espoo, Finland, April 21, 2016 -- Nokia announced today that its Board of Directors (the "Board") has resolved to convene the Annual General Meeting on June 16, 2016 and that the Board and its committees submit the...
YPO Prepares to Feature Far-Reaching Trends, Breakthroughs During Global Innovation Week
Apr 21, 2016 09:15 am UTC| Business
IRVING, Texas, April 21, 2016 -- YPO, the premier global network of chief executives and business leaders, is preparing to showcase global innovations through its new initiative YPO Innovation Week, a series of more than...
Apr 21, 2016 09:01 am UTC| Business
HEIDELBERG, Germany, April 21, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced today the presentation...
Apr 21, 2016 09:01 am UTC| Business
HEIDELBERG, Germany, April 21, 2016 -- Affimed N.V. (Nasdaq:AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, announced that the Company...
EXEL INDUSTRIES: 2015-2016 first-half results Increased income and Strategic Acquisition in the USA
Apr 21, 2016 07:08 am UTC| Business
PARIS, April 21, 2016 -- Revenue of €309.5 million, up €11 million from February 2015. Current Operating Income (EBIT) up to €8.3 million from -€6.1 million. Net profit in the...
Real journalists report the news, they don’t make it.
Apr 21, 2016 06:35 am UTC| Insights & Views Business
At QUTs Digital Media Research Centre we are about to complete ARC-funded research on the state of the Australian political news media. A key finding of the work has been the nearly complete withdrawal of commercial...
Apr 21, 2016 06:05 am UTC| Business
MARTINSRIED / MUNICH, Germany, April 21, 2016 -- MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; OTC: MPSYY) announced today that its partner Novartis has confirmed that a phase 2b/3 study examining bimagrumab...